RETRACTED ARTICLE:Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11605-11612

  Liu, Shunli ^a   Gong, Zhenyu ^b   Chen, Mingrui ^a   Liu, Benli ^a   Bian, Donghui ^a   Wu, Kai ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b Department of Gastroenterology   (China)

Author keywords

Aldeflour; Cancer stem cell; CD133; Lgr5; Side population; Skin squamous cell carcinoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; LGR5 PROTEIN, HUMAN; MESSENGER RNA; PEPTIDE; TUMOR MARKER;

APOPTOSIS; CANCER STEM CELL; CASE CONTROL STUDY; CELL PROLIFERATION; COMPARATIVE STUDY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; WESTERN BLOTTING;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; GLYCOPROTEINS; HUMANS; NEOPLASTIC STEM CELLS; PEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84927786971     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2488-6     Document Type: TB

References (24)

1. Rahimi S. Squamous cell carcinoma of skin: a brief review. Clin Ter. 2013;164:143–7.
2. Petersson M, Niemann C. Stem cell dynamics and heterogeneity: implications for epidermal regeneration and skin cancer. Curr Med Chem. 2012;19:5984–92.
3. Perez-Losada J, Balmain A. Stem-cell hierarchy in skin cancer. Nat Rev Cancer. 2003;3:434–43.
4. Nagata T, Sakakura C, Komiyama S, Miyashita A, Nishio M, Murayama Y, et al. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res. 2011;31:495–500.
5. Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer. 2010;102:1265–75.
6. Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, et al. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther. 2010;10:1182–90.
7. Ottaiano A. Finding markers for cancer stem cells in renal cell carcinoma: looking beyond CD133. Cell Cycle. 2010;9:4431.
8. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res. 2008;6:1146–53.
9. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, Svendsen A, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer. 2008;122:761–8.
10. Takubo K, Ohmura M, Azuma M, Nagamatsu G, Yamada W, Arai F, et al. Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest. Cell Stem Cell. 2008;2:170–82.
11. Duester G. Families of retinoid dehydrogenases regulating vitamin a function: production of visual pigment and retinoic acid. Eur J Biochem. 2000;267:4315–24.
12. Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R, Gianni AM. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 1996;87:1097–103.
13. Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, Hole N, et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells. 2004;22:1142–51.
14. Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC, et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells. 2008;26:611–20.
15. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 2004;104:1648–55.
16. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 2006;107:2162–9.
17. Liu Y, Jiang X, Zeng Y, Zhou H, Yang J, Cao R: Proliferating pancreatic beta-cells upregulate ALDH. Histochem Cell Biol 2014
18. Zhang L, Wang L, Liu X, Zheng D, Liu S, Liu C. ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. PLoS ONE. 2014;9:e96204.
19. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 2011;71:3991–4001.
20. Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 2011;7:292–306.
21. Kinzel B, Pikiolek M, Orsini V, Sprunger J, Isken A, Zietzling S, et al. Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. Dev Biol. 2014;390:181–90.
22. Haegebarth A, Clevers H. Wnt signaling, Lgr5, and stem cells in the intestine and skin. Am J Pathol. 2009;174:715–21.
23. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis. 2007;45:593–605.
24. Xiao X, Chen Z, Shiota C, Prasadan K, Guo P, El-Gohary Y, et al. No evidence for beta cell neogenesis in murine adult pancreas. J Clin Invest. 2013;123:2207–17.